HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS

Welcome to FDAweb Pay Per View Search our 45,647 - story database FREE   Free Items  Warning Letters  FDA Notices  FDA Calendar    FDA Whistleblowers          << Prev  39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 Next >>   Government OKs Texas Influenza-Vaccine Facility [150 Words] [ Price : $7.95] HHS approves an influenza vaccines manufacturing facility in Bryan-College Station, TX as part of a partnership between GlaxoSmithKline and Texas A&M University and the Center for Innovation in Advanced Development and Manufacturing. 03/26/2013     FDA Sends Info on Supplement Labeling to OMB [53 Words] [ Price : $7.95] Federal Register Notice: FDA submits a proposed collection to the Office of Management and Budget on food labeling and notification procedures for statements on dietary supplements. 03/26/2013     FDA Won’t Change Mesalamine Bio Recommendations [241 Words] [ Price : $7.95] FDA denies a Warner Chilcott petition asking that it change its bioequivalence recommendations for generic versions of orally-ingested modified-release mesalamine drugs. 03/26/2013     IoM Workshop Examines Hurdles to Advancing Personalized Medicine [487 Words] [ Price : $7.95] An Institute of Medicine workshop examines human genome sequencing and the identification of links between specific genetic variants and diseases and their potential to direct patient. 03/26/2013     Inspection Finds QS Problems at Instratek [221 Words] [ Price : $7.95] FDA’s Dallas District Office warns Instratek about QS violations in its Houston, TX, manufacturing facility. 03/26/2013     QS Violations Found at Fresenius Facility [122 Words] [ Price : $7.95] FDA’s Denver District Office warns Fresenius about QS violations at its Ogden, UT, manufacturing plant. 03/26/2013     Multiple QS, MDR Violations Found at Italy’s Fisioline [398 Words] [ Price : $7.95] FDA warns Italian laser device manufacturer Fisioline about multiple QS and MDR violations in its manufacturing facility. 03/26/2013     FDA Updates CDRH Address in Regs [68 Words] [ Price : $7.95] Federal Register Final rule: FDA amends a final rule to reflect an office relocation for CDRH. 03/26/2013     FDA Orphan Drug Status for Acceleron Blood Disorder Drug [219 Words] [ Price : $7.95] FDA grants Acceleron Pharma two orphan drug designations for ACE-536 for treating beta-thalassemia and myelodysplastic syndromes, two rare blood disorders characterized by severe and chronic anemia. 03/26/2013     FDA Posts Spacelabs’ Anesthesia Workstation Class 1 Recall [105 Words] [ Price : $7.95] FDA posts a Class 1 recall notice on Spacelabs’ BleaseSirius Anesthesia Workstation due to a defect in the device’s CAS I/II Absorbers that may cause a condition leading to an increase in the carbon dioxide concentration. 03/26/2013     << Prev  39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58  Next >>

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com